The 20 Best Color Blindness Doctors near Bronx, NY

Elona Dhrami is an Ophthalmologist in Bronx, New York. Dr. Dhrami is rated as a Distinguished provider by MediFind in the treatment of Color Blindness. Her top areas of expertise are Color Blindness, Kallikrein Hypertension, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Vitrectomy.

Jeremy Chess is an Ophthalmologist in Bronx, New York. Dr. Chess is rated as a Distinguished provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Color Blindness, Diabetic Retinopathy, Kallikrein Hypertension, and Late-Onset Retinal Degeneration.

Issac Moradi is an Ophthalmologist in Bronx, New York. Dr. Moradi is rated as an Advanced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Diabetic Retinopathy, Color Blindness, Kallikrein Hypertension, and Late-Onset Retinal Degeneration.

Navid Hakimian is an Ophthalmologist in Bronx, New York. Dr. Hakimian is rated as an Advanced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Diabetic Retinopathy, Color Blindness, Ocular Toxoplasmosis, and Retinal Detachment.

Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Thomas L. Slamovits is an internationally renowned medical expert with extensive experience in neuro-ophthalmic disorders and orbital and systemic diseases. He has a special interest in optic nerve and orbital diseases and has popularized the diagnosis of orbital tumors by fine needle aspiration biopsy. He also has an interest and expertise in the ocular manifestations of systemic diseases, such as multiple sclerosis, sarcoidosis and cancer and has an interest in the effects of certain medications on the visual system. To read about one of Dr. Slamovits' cases, please see this case, published in the November 14, 2014 issue of The New York Times Magazine, and also in more detail on the New York Times Well Blog feature Think Like a Doctor (Going Blind and Going Blind Solved!). Dr. Slamovits is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Strabismus, Optic Nerve Atrophy, Optic Atrophy Type 1, and Esotropia.

Scott E. Brodie, MD, Ph.D., is a Professor of Clinical Ophthalmology and Attending Ophthalmologist in the Department of Ophthalmology. He is an internationally known clinician-scientist, and a leader in the use of electrophysiologic techniques for diagnosing of visual impairments in children and adults.Dr. Brodie is a graduate of the combined MD-PhD program at Weill-Cornell Medical College and The Rockefeller University in New York. He completed his PhD in retinal physiology in the laboratory of Nobel Laureate H. K. Hartline, under the supervision of Dr. Floyd Ratliff and Prof. Bruce Knight. He completed a medical internship and residency training in ophthalmology at The New York Hospital, and subsequently received fellowship training in medical retinal disorders and clinical electrophysiology of vision at New York University and Bellevue Hospital under the supervision of Dr. Ronald Carr, with support as a John Kluge Fellow of the Retinitis Pigmentosa Foundation.He is a fellow of the American Academy of Ophthalmology, and a fellow of the Association for Research in Vision and Ophthalmology. He is a member of the International Society for Clinical Electrophysiology of Vision, the International Society for Genetic Eye Disease, and the Ophthalmic Genetics Study Club. Dr. Brodie has been honored with the Senior Achievement Award of the American Academy of Ophthalmology, as well as the Academy's Secretariat Award for Education.Dr. Brodie’s research centers on improving methodologies for electrophysiologic testing, and descriptions of novel findings in patients with inherited and metabolic retinal disorders. He has been a key member of the teams which have introduced important new therapies, including enzyme-replacement therapy for Fabry disease, and intra-arterial chemotherapy for retinoblastoma, which has increased the rate of salvage of diseased eyes in the most severely affected patients from 20% to over 90%.Dr. Brodie has published extensively on electrophysiology and retinal disorders. He has a particular interest in clinical optics, and has served as Chair of the Editorial committee for the American Academy of Ophthalmology’s Basic and Clinical Science Course on Clinical Optics for the past ten years. In his spare time, he enjoys reading mathematics, and playing the oboe in local orchestras and chamber groups. Dr. Brodie is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Retinoblastoma, Retinitis Pigmentosa, Cone-Rod Dystrophy, Retinopathy Pigmentary Mental Retardation, and Vitrectomy.

"Stephen H. Tsang, M.D, Ph.D. is an acclaimed clinical geneticist in the care of individuals with retinal degenerations. He has been culturing stem cells since 1992 and created the first mouse model for a recessive form of retinitis pigmentosa (RP) by applying genome engineering to stem cell technology in 1995. He successfully treated preclinical models of Pde6a, Pde6b, Mfrp, Rho, Cngb1 and autosomal recessive bestrophin retinopathies.He has expertise in designing and testing genome engineering strategies in pre-clinical models, developing patient-specific knock-in models, generating of patient cell lines and providing care to patients with a precision medicine approach. He is also leading efforts in FDA trials for gene therapies, including PDE6A, RAB geranylgeranyl transferase, RPGR, CNGB3, CNGA3 and ABCA4 retinopathies. He wrote 3 books: “Precision Medicine, CRISPR, and Genome Engineering: Moving from Association to Biology and Therapeutics"" and “Stem Cell Biology and Regenerative Medicine in Ophthalmology”, Springer Press, NY; and “CRISPR Genome Surgery in Stem Cells and Disease Tissues”, Elsevier Inc. He is an elected member of several honorary societies including the American Society for Clinical Investigation, Alcon Research Institute and American Ophthalmological Society. He is consistently named to various NIH study sections (DPVS standing member 2014-8 and PED2 2022-6) and other review committees; Alcon Research Institute Grant Review Committee (2022-27), Scientific Advisory Panel - Research to Prevent Blindness (RPB, 2019-29), Chair of American Ophthalmological Society Thesis Review Committee (2022-2023). Many of his publications are in widely-read general interest journals such as Science, NEJM, Lancet, Cell Stem Cell, Nature Genetics, and Journal of Clinical Investigation, which attests to the broad impact that his work has had.Dr. Tsang received a resident teaching award in 2008 and was the Columbia Ophthalmology Basic Science Course Director (2006-2018). Dr. Tsang graduated from Johns Hopkins University, where he began his medical genetics training under the tutelage of Professor Victor A. McKusick. He received his M.D. and Ph.D. degrees from the NIH-National Institute of General Medical Sciences Medical Scientist Training Program (MSTP) at Columbia University. Dr. Tsang then completed his residency at Jules Stein Eye Institute/UCLA, followed by studies with Professors Alan C. Bird and Graham E. Holder on improving the care of individuals with macular degenerations.". Dr. Tsang is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Sorsby Fundus Dystrophy, Leber Congenital Amaurosis, and Usher Syndrome.

Tarun Sharma is an Ophthalmologist in New York, New York. Dr. Sharma is rated as an Advanced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Diabetic Retinopathy, Late-Onset Retinal Degeneration, X-Linked Juvenile Retinoschisis, Vitrectomy, and Trabeculectomy. Dr. Sharma is currently accepting new patients.

Gary Hirshfield is an Ophthalmologist in Fresh Meadows, New York. Dr. Hirshfield is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Bietti Crystalline Dystrophy (BCD).

Damon Pettinelli is an Ophthalmologist in Bronx, New York. Dr. Pettinelli is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Pterygium, and Cataract.

Fiona Pathay is an Ophthalmologist in Bronx, New York. Dr. Pathay is rated as an Experienced provider by MediFind in the treatment of Color Blindness. Her top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Dry Eye Syndrome, and Cataract.

Judith Gurland is an Ophthalmologist in Bronx, New York. Dr. Gurland is rated as an Experienced provider by MediFind in the treatment of Color Blindness. Her top areas of expertise are Uveitis, Neuroretinitis, Strabismus, and Brown Syndrome.

Rashmi Verma is a Neurologist in Bronx, New York. Dr. Verma is rated as an Experienced provider by MediFind in the treatment of Color Blindness. Her top areas of expertise are Papilledema, Meningitis, Increased Intracranial Pressure, and Pseudotumor Cerebri Syndrome.

Vlad Diaconita is an Ophthalmologist in New York, New York. Dr. Diaconita is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Acatalasemia, Neuroretinitis, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Diaconita is currently accepting new patients.

Jeffrey Odel is an Ophthalmologist in New York, New York. Dr. Odel is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Optic Nerve Atrophy, Optic Atrophy Type 1, Strabismus, Temporal Arteritis, and Vitrectomy. Dr. Odel is currently accepting new patients.

Michael Boron is an Ophthalmologist in Mount Vernon, New York. Dr. Boron is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Glaucoma, Pterygium, Presbyopia, and Pinguecula.

Nicholas Nissirios is an Ophthalmologist in Astoria, New York. Dr. Nissirios is rated as an Experienced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Dry Eye Syndrome, Allergic Conjunctivitis, Conjunctivitis (Pink Eye), and Eyelid Bump.

Gonzalo Vicente is an Ophthalmologist in New York, New York. Dr. Vicente is rated as an Advanced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Strabismus, Esotropia, Amblyopia, and Isolated Duane Retraction Syndrome.

Matthew Feinsod is an Ophthalmologist in Long Island City, New York. Dr. Feinsod is rated as an Advanced provider by MediFind in the treatment of Color Blindness. His top areas of expertise are Color Blindness, X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa, and Retinopathy Pigmentary Mental Retardation.